Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Completed(1)
Other(1)

Detailed Status

Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed150%
unknown150%

Recent Activity

0 active trials
Showing 2 of 2
completednot_applicable

Transillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID)

NCT03477552
unknownnot_applicable

Application of Standardized Cleaning and Disinfection Mode of HFT Surface in Hospital Infection Prevention and Control

NCT04920240

Clinical Trials (2)

Showing 2 of 2 trials
NCT03477552Not Applicable

Transillumination Device for Peripheral Intravenous Placement in Patients With Sickle Cell Disease (PERFID)

Completed
NCT04920240Not Applicable

Application of Standardized Cleaning and Disinfection Mode of HFT Surface in Hospital Infection Prevention and Control

Unknown

All 2 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
2